These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12521638)
1. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. Dudek D; Zmudka K; Kaluza GL; Kuta M; Pieniazek P; Przewlocki T; Zorkun C; Legutko J; Gajos G; Bartuś S; Bryniarski L; Dziewierz A; Pasowicz M; Dubiel JS Am J Cardiol; 2003 Jan; 91(2):227-9. PubMed ID: 12521638 [No Abstract] [Full Text] [Related]
2. Coupling drug and catheter therapy for myocardial infarction. Lincoff AM JAMA; 2004 Feb; 291(8):1000-2. PubMed ID: 14982917 [No Abstract] [Full Text] [Related]
3. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A; JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910 [TBL] [Abstract][Full Text] [Related]
4. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction. Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430 [TBL] [Abstract][Full Text] [Related]
5. Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibition. Bush HS J Emerg Med; 2003 Nov; 25(4):421-6. PubMed ID: 14654184 [TBL] [Abstract][Full Text] [Related]
6. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E; Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099 [TBL] [Abstract][Full Text] [Related]
7. Facilitated PCI for ST segment elevation myocardial infarction. Young JJ J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663 [No Abstract] [Full Text] [Related]
8. Triple therapy for acute myocardial infarction: combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention. Herrmann HC Am J Cardiol; 2000 Apr; 85(8A):10C-6C. PubMed ID: 10793175 [TBL] [Abstract][Full Text] [Related]
9. [GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]. Nordt TK; Peter K; Bode C Herz; 2001 Apr; 26 Suppl 1():42-5. PubMed ID: 11349626 [TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Kleiman NS; Lincoff AM; Kereiakes DJ; Miller DP; Aguirre FV; Anderson KM; Weisman HF; Califf RM; Topol EJ Circulation; 1998 May; 97(19):1912-20. PubMed ID: 9609084 [TBL] [Abstract][Full Text] [Related]
11. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition. Califf RM Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314 [TBL] [Abstract][Full Text] [Related]